List of Tables
Table 1. Oncology (Anti-cancer Drugs) Market Trends
Table 2. Oncology (Anti-cancer Drugs) Market Drivers & Opportunity
Table 3. Oncology (Anti-cancer Drugs) Market Challenges
Table 4. Oncology (Anti-cancer Drugs) Market Restraints
Table 5. Global Oncology (Anti-cancer Drugs) Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Company (2019-2024)
Table 7. Global Oncology (Anti-cancer Drugs) Sales Volume by Company (2019-2024) & (K MT)
Table 8. Global Oncology (Anti-cancer Drugs) Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Oncology (Anti-cancer Drugs) Price by Company (2019-2024) & (USD/MT)
Table 10. Key Manufacturers Oncology (Anti-cancer Drugs) Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Oncology (Anti-cancer Drugs) Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Oncology (Anti-cancer Drugs)
Table 13. Global Oncology (Anti-cancer Drugs) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology (Anti-cancer Drugs) as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Oncology (Anti-cancer Drugs) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Oncology (Anti-cancer Drugs) Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Oncology (Anti-cancer Drugs) Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Oncology (Anti-cancer Drugs) Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Oncology (Anti-cancer Drugs) Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Oncology (Anti-cancer Drugs) Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)
Table 22. Global Oncology (Anti-cancer Drugs) Sales Volume by Type (2019-2024) & (K MT)
Table 23. Global Oncology (Anti-cancer Drugs) Sales Volume by Type (2025-2030) & (K MT)
Table 24. Global Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Oncology (Anti-cancer Drugs) Price by Type (2019-2024) & (USD/MT)
Table 27. Global Oncology (Anti-cancer Drugs) Price by Type (2025-2030) & (USD/MT)
Table 28. Global Oncology (Anti-cancer Drugs) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Oncology (Anti-cancer Drugs) Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Oncology (Anti-cancer Drugs) Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Oncology (Anti-cancer Drugs) Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Oncology (Anti-cancer Drugs) Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Oncology (Anti-cancer Drugs) Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)
Table 34. Global Oncology (Anti-cancer Drugs) Sales Volume by Application (2019-2024) & (K MT)
Table 35. Global Oncology (Anti-cancer Drugs) Sales Volume by Application (2025-2030) & (K MT)
Table 36. Global Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Oncology (Anti-cancer Drugs) Price by Application (2019-2024) & (USD/MT)
Table 39. Global Oncology (Anti-cancer Drugs) Price by Application (2025-2030) & (USD/MT)
Table 40. Global Oncology (Anti-cancer Drugs) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Oncology (Anti-cancer Drugs) Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Oncology (Anti-cancer Drugs) Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Oncology (Anti-cancer Drugs) Sales Value by Region (2019-2024) & (%)
Table 44. Global Oncology (Anti-cancer Drugs) Sales Value by Region (2025-2030) & (%)
Table 45. Global Oncology (Anti-cancer Drugs) Sales Volume by Region (K MT): 2019 VS 2023 VS 2030
Table 46. Global Oncology (Anti-cancer Drugs) Sales Volume by Region (2019-2024) & (K MT)
Table 47. Global Oncology (Anti-cancer Drugs) Sales Volume by Region (2025-2030) & (K MT)
Table 48. Global Oncology (Anti-cancer Drugs) Sales Volume by Region (2019-2024) & (%)
Table 49. Global Oncology (Anti-cancer Drugs) Sales Volume by Region (2025-2030) & (%)
Table 50. Global Oncology (Anti-cancer Drugs) Average Price by Region (2019-2024) & (USD/MT)
Table 51. Global Oncology (Anti-cancer Drugs) Average Price by Region (2025-2030) & (USD/MT)
Table 52. Key Countries/Regions Oncology (Anti-cancer Drugs) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Oncology (Anti-cancer Drugs) Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Oncology (Anti-cancer Drugs) Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Oncology (Anti-cancer Drugs) Sales Volume, (2019-2024) & (K MT)
Table 56. Key Countries/Regions Oncology (Anti-cancer Drugs) Sales Volume, (2025-2030) & (K MT)
Table 57. Roche Company Information
Table 58. Roche Introduction and Business Overview
Table 59. Roche Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Roche Oncology (Anti-cancer Drugs) Product Offerings
Table 61. Roche Recent Development
Table 62. Novartis Company Information
Table 63. Novartis Introduction and Business Overview
Table 64. Novartis Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 65. Novartis Oncology (Anti-cancer Drugs) Product Offerings
Table 66. Novartis Recent Development
Table 67. Celgene Company Information
Table 68. Celgene Introduction and Business Overview
Table 69. Celgene Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 70. Celgene Oncology (Anti-cancer Drugs) Product Offerings
Table 71. Celgene Recent Development
Table 72. Amgen Company Information
Table 73. Amgen Introduction and Business Overview
Table 74. Amgen Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 75. Amgen Oncology (Anti-cancer Drugs) Product Offerings
Table 76. Amgen Recent Development
Table 77. Johnson & Johnson Company Information
Table 78. Johnson & Johnson Introduction and Business Overview
Table 79. Johnson & Johnson Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 80. Johnson & Johnson Oncology (Anti-cancer Drugs) Product Offerings
Table 81. Johnson & Johnson Recent Development
Table 82. GlaxoSmithKline Company Information
Table 83. GlaxoSmithKline Introduction and Business Overview
Table 84. GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 85. GlaxoSmithKline Oncology (Anti-cancer Drugs) Product Offerings
Table 86. GlaxoSmithKline Recent Development
Table 87. Eli lilly Company Information
Table 88. Eli lilly Introduction and Business Overview
Table 89. Eli lilly Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 90. Eli lilly Oncology (Anti-cancer Drugs) Product Offerings
Table 91. Eli lilly Recent Development
Table 92. Pfizer Company Information
Table 93. Pfizer Introduction and Business Overview
Table 94. Pfizer Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 95. Pfizer Oncology (Anti-cancer Drugs) Product Offerings
Table 96. Pfizer Recent Development
Table 97. Merck Company Information
Table 98. Merck Introduction and Business Overview
Table 99. Merck Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 100. Merck Oncology (Anti-cancer Drugs) Product Offerings
Table 101. Merck Recent Development
Table 102. Sanofi Company Information
Table 103. Sanofi Introduction and Business Overview
Table 104. Sanofi Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 105. Sanofi Oncology (Anti-cancer Drugs) Product Offerings
Table 106. Sanofi Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Oncology (Anti-cancer Drugs) Downstream Customers
Table 110. Oncology (Anti-cancer Drugs) Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncology (Anti-cancer Drugs) Product Picture
Figure 2. Global Oncology (Anti-cancer Drugs) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Oncology (Anti-cancer Drugs) Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Oncology (Anti-cancer Drugs) Sales Volume (2019-2030) & (K MT)
Figure 5. Global Oncology (Anti-cancer Drugs) Sales Price (2019-2030) & (USD/MT)
Figure 6. Oncology (Anti-cancer Drugs) Report Years Considered
Figure 7. Global Oncology (Anti-cancer Drugs) Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Oncology (Anti-cancer Drugs) Players Sales Volume Ranking (2023) & (K MT)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Oncology (Anti-cancer Drugs) Revenue in 2023
Figure 10. Oncology (Anti-cancer Drugs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Blood Cancer Picture
Figure 12. Breast Cancer Picture
Figure 13. Gastrointestinal Cancer Picture
Figure 14. Prostate Cancer Picture
Figure 15. Others Picture
Figure 16. Global Oncology (Anti-cancer Drugs) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Oncology (Anti-cancer Drugs) Sales Value Market Share by Type, 2023 & 2030
Figure 18. Global Oncology (Anti-cancer Drugs) Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)
Figure 19. Global Oncology (Anti-cancer Drugs) Sales Volume Market Share by Type, 2023 & 2030
Figure 20. Global Oncology (Anti-cancer Drugs) Price by Type (2019-2030) & (USD/MT)
Figure 21. Product Picture of Chemotherapy
Figure 22. Product Picture of Targeted Therapy
Figure 23. Product Picture of Immunotherapy (Biologic Therapy)
Figure 24. Product Picture of Hormonal Therapy
Figure 25. Product Picture of Others
Figure 26. Global Oncology (Anti-cancer Drugs) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Oncology (Anti-cancer Drugs) Sales Value Market Share by Application, 2023 & 2030
Figure 28. Global Oncology (Anti-cancer Drugs) Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)
Figure 29. Global Oncology (Anti-cancer Drugs) Sales Volume Market Share by Application, 2023 & 2030
Figure 30. Global Oncology (Anti-cancer Drugs) Price by Application (2019-2030) & (USD/MT)
Figure 31. North America Oncology (Anti-cancer Drugs) Sales Value (2019-2030) & (US$ Million)
Figure 32. North America Oncology (Anti-cancer Drugs) Sales Value by Country (%), 2023 VS 2030
Figure 33. Europe Oncology (Anti-cancer Drugs) Sales Value (2019-2030) & (US$ Million)
Figure 34. Europe Oncology (Anti-cancer Drugs) Sales Value by Country (%), 2023 VS 2030
Figure 35. Asia Pacific Oncology (Anti-cancer Drugs) Sales Value (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Oncology (Anti-cancer Drugs) Sales Value by Country (%), 2023 VS 2030
Figure 37. South America Oncology (Anti-cancer Drugs) Sales Value (2019-2030) & (US$ Million)
Figure 38. South America Oncology (Anti-cancer Drugs) Sales Value by Country (%), 2023 VS 2030
Figure 39. Middle East & Africa Oncology (Anti-cancer Drugs) Sales Value (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Oncology (Anti-cancer Drugs) Sales Value by Country (%), 2023 VS 2030
Figure 41. Key Countries/Regions Oncology (Anti-cancer Drugs) Sales Value (%), (2019-2030)
Figure 42. Key Countries/Regions Oncology (Anti-cancer Drugs) Sales Volume (%), (2019-2030)
Figure 43. United States Oncology (Anti-cancer Drugs) Sales Value, (2019-2030) & (US$ Million)
Figure 44. United States Oncology (Anti-cancer Drugs) Sales Value by Type (%), 2023 VS 2030
Figure 45. United States Oncology (Anti-cancer Drugs) Sales Value by Application (%), 2023 VS 2030
Figure 46. Europe Oncology (Anti-cancer Drugs) Sales Value, (2019-2030) & (US$ Million)
Figure 47. Europe Oncology (Anti-cancer Drugs) Sales Value by Type (%), 2023 VS 2030
Figure 48. Europe Oncology (Anti-cancer Drugs) Sales Value by Application (%), 2023 VS 2030
Figure 49. China Oncology (Anti-cancer Drugs) Sales Value, (2019-2030) & (US$ Million)
Figure 50. China Oncology (Anti-cancer Drugs) Sales Value by Type (%), 2023 VS 2030
Figure 51. China Oncology (Anti-cancer Drugs) Sales Value by Application (%), 2023 VS 2030
Figure 52. Japan Oncology (Anti-cancer Drugs) Sales Value, (2019-2030) & (US$ Million)
Figure 53. Japan Oncology (Anti-cancer Drugs) Sales Value by Type (%), 2023 VS 2030
Figure 54. Japan Oncology (Anti-cancer Drugs) Sales Value by Application (%), 2023 VS 2030
Figure 55. South Korea Oncology (Anti-cancer Drugs) Sales Value, (2019-2030) & (US$ Million)
Figure 56. South Korea Oncology (Anti-cancer Drugs) Sales Value by Type (%), 2023 VS 2030
Figure 57. South Korea Oncology (Anti-cancer Drugs) Sales Value by Application (%), 2023 VS 2030
Figure 58. Southeast Asia Oncology (Anti-cancer Drugs) Sales Value, (2019-2030) & (US$ Million)
Figure 59. Southeast Asia Oncology (Anti-cancer Drugs) Sales Value by Type (%), 2023 VS 2030
Figure 60. Southeast Asia Oncology (Anti-cancer Drugs) Sales Value by Application (%), 2023 VS 2030
Figure 61. India Oncology (Anti-cancer Drugs) Sales Value, (2019-2030) & (US$ Million)
Figure 62. India Oncology (Anti-cancer Drugs) Sales Value by Type (%), 2023 VS 2030
Figure 63. India Oncology (Anti-cancer Drugs) Sales Value by Application (%), 2023 VS 2030
Figure 64. Oncology (Anti-cancer Drugs) Industrial Chain
Figure 65. Oncology (Anti-cancer Drugs) Manufacturing Cost Structure
Figure 66. Channels of Distribution (Direct Sales, and Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed